A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.

Clinical trial NCT00808288 · COMPLETED

Trial details

NCT number: NCT00808288
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive Lung Diseases Lung Diseases, Obstructive

Start date: 2010-03-01
Primary completion: 2010-12-01
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.